Fragmentomic Liquid Biopsy Enables Non-invasive Detection, Molecular Subtyping and Lymph Node Assessment in Early Breast Cancer

preprint OA: closed
Full text JSON View at publisher

Abstract

Abstract Breast cancer (BC) remains a leading global health concern in women. While mammography is the standard screening tool, its efficacy is limited by the high breast density and accessibility challenges in China. Here, we conducted a multicenter case-control study (NCT06016790) involving 503 patients with malignant BC and 289 benign controls across seven hospitals to develop TuFEst, a machine learning model utilizing multi-feature cell-free DNA (cfDNA) fragmentomics. TuFEst showed excellent early detection performance (95.0% sensitivity and 78.3% specificity), maintaining 96.2% accuracy in an imaging-pathological inconsistency cohort (n=26). To broaden its clinical application, we extended TuFEst to molecular subtyping (TuFEst-MS) and lymph node metastasis prediction (TuFEst-LN). TuFEst-MS yielded AUCs of 0.906 (ER + /PR + HER2 − ), 0.925 (HER2 + ), and 0.891 (triple-negative) with 85.7% accuracy in the oligometastatic validation cohort (n=21). TuFEst-LN achieved a negative predictive value (NPV) of 95.2%, which improved to 97.6% in an independent cohort (n=124) with discordant axillary imaging pathology. RNA-seq of paired bulk tumor samples (n=79) demonstrated that elevated TuFEst-derived cancer scores were associated with aggressive tumor characteristics, particularly enriched immune responses and epithelial-mesenchymal transition (EMT) signatures, emphasizing the clinical importance of early detection. Our study established cfDNA fragmentomics as an integrated liquid biopsy solution for BC management, enabling concurrent detection, molecular subtyping, and lymph node evaluation with transformative clinical potential.
Full text 21,640 characters · extracted from preprint-html · click to expand
Fragmentomic Liquid Biopsy Enables Non-invasive Detection, Molecular Subtyping and Lymph Node Assessment in Early Breast Cancer | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Fragmentomic Liquid Biopsy Enables Non-invasive Detection, Molecular Subtyping and Lymph Node Assessment in Early Breast Cancer Chao Ni, Yuxuan Zhu, Siwei Zheng, Yingkuan Shao, Jun Zhou, Xidong Gu, and 21 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6866836/v1 This work is licensed under a CC BY 4.0 License Status: Published Journal Publication published 06 Mar, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Abstract Breast cancer (BC) remains a leading global health concern in women. While mammography is the standard screening tool, its efficacy is limited by the high breast density and accessibility challenges in China. Here, we conducted a multicenter case-control study (NCT06016790) involving 503 patients with malignant BC and 289 benign controls across seven hospitals to develop TuFEst, a machine learning model utilizing multi-feature cell-free DNA (cfDNA) fragmentomics. TuFEst showed excellent early detection performance (95.0% sensitivity and 78.3% specificity), maintaining 96.2% accuracy in an imaging-pathological inconsistency cohort (n=26). To broaden its clinical application, we extended TuFEst to molecular subtyping (TuFEst-MS) and lymph node metastasis prediction (TuFEst-LN). TuFEst-MS yielded AUCs of 0.906 (ER + /PR + HER2 − ), 0.925 (HER2 + ), and 0.891 (triple-negative) with 85.7% accuracy in the oligometastatic validation cohort (n=21). TuFEst-LN achieved a negative predictive value (NPV) of 95.2%, which improved to 97.6% in an independent cohort (n=124) with discordant axillary imaging pathology. RNA-seq of paired bulk tumor samples (n=79) demonstrated that elevated TuFEst-derived cancer scores were associated with aggressive tumor characteristics, particularly enriched immune responses and epithelial-mesenchymal transition (EMT) signatures, emphasizing the clinical importance of early detection. Our study established cfDNA fragmentomics as an integrated liquid biopsy solution for BC management, enabling concurrent detection, molecular subtyping, and lymph node evaluation with transformative clinical potential. Biological sciences/Cancer/Gynaecological cancer Biological sciences/Computational biology and bioinformatics/Genome informatics Biological sciences/Biotechnology/Sequencing Breast cancer early detection cell-free DNA whole-genome sequencing machine learning Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryTable1.xlsx Supplementary Table 1 SupplementaryTable2.xlsx Supplementary Table 2 SupplementaryTable3.docx Supplementary Table 3 Supplementarytable4.docx Supplementary Table 4 Cite Share Download PDF Status: Published Journal Publication published 06 Mar, 2026 Read the published version in Nature Communications → Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6866836","acceptedTermsAndConditions":true,"allowDirectSubmit":false,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":474028395,"identity":"01e9e47f-a693-4e17-aaee-63d4c219e39e","order_by":0,"name":"Chao Ni","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA0UlEQVRIie3RsQrCMBCA4StCuwS7poM+QyAgguCzJAjtIp0FBQNCtuKrCII4phR0iboK7s6uXcS0k1NIN8H83HJw33QAPt8vpswEAiAGYGbtdSCJ6EKgIUS1qwPpPy6lqo/TIb2pJ4bFhIvooqwkueasLPSMjpRKMeiMC5QzKyEakSqQPX4oRYoDWXGBEXEha77fgCFvd1LxXdgQ4UASQ8pCninWMBuzU0YlmttJXyP6quVyGG81v79Wk8E20nbyFWLtM0PXe1OkOhz7fD7fP/UBtSFHoYk2CQoAAAAASUVORK5CYII=","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":true,"prefix":"","firstName":"Chao","middleName":"","lastName":"Ni","suffix":""},{"id":474028396,"identity":"93afaa77-befd-4fbf-9493-7d660143a9c9","order_by":1,"name":"Yuxuan Zhu","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Yuxuan","middleName":"","lastName":"Zhu","suffix":""},{"id":474028397,"identity":"0711cfb2-e8d6-4080-a7eb-5eace16a015b","order_by":2,"name":"Siwei Zheng","email":"","orcid":"https://orcid.org/0000-0002-9771-7379","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Siwei","middleName":"","lastName":"Zheng","suffix":""},{"id":474028398,"identity":"d6ed55d7-8c12-4c2d-99d8-4f7b6c8d54f7","order_by":3,"name":"Yingkuan Shao","email":"","orcid":"https://orcid.org/0000-0001-9683-5691","institution":"Zhejiang University","correspondingAuthor":false,"prefix":"","firstName":"Yingkuan","middleName":"","lastName":"Shao","suffix":""},{"id":474028399,"identity":"83436771-33f9-4ee4-8e32-0577c986558b","order_by":4,"name":"Jun Zhou","email":"","orcid":"","institution":"Affiliated Hangzhou First People's Hospital,","correspondingAuthor":false,"prefix":"","firstName":"Jun","middleName":"","lastName":"Zhou","suffix":""},{"id":474028400,"identity":"736bca73-229d-4e6a-b474-262dd8ab211d","order_by":5,"name":"Xidong Gu","email":"","orcid":"","institution":"The First Affiliated Hospital of Zhejiang Chinese Medical University","correspondingAuthor":false,"prefix":"","firstName":"Xidong","middleName":"","lastName":"Gu","suffix":""},{"id":474028401,"identity":"8a42fcf7-1346-4da9-a465-4b3c5b305006","order_by":6,"name":"Lesang Shen","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Lesang","middleName":"","lastName":"Shen","suffix":""},{"id":474028402,"identity":"016521a4-556d-4007-8765-f81284247fca","order_by":7,"name":"Xue Li","email":"","orcid":"https://orcid.org/0000-0001-6880-2577","institution":"School of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China","correspondingAuthor":false,"prefix":"","firstName":"Xue","middleName":"","lastName":"Li","suffix":""},{"id":474028403,"identity":"cec76fa1-7975-48eb-bf75-43e3343a09b3","order_by":8,"name":"Wenjia Liu","email":"","orcid":"","institution":"OmixPath Inc., China","correspondingAuthor":false,"prefix":"","firstName":"Wenjia","middleName":"","lastName":"Liu","suffix":""},{"id":474028404,"identity":"de318a67-2664-470f-b834-de79887b544c","order_by":9,"name":"Wei Xue","email":"","orcid":"","institution":"OmixScience Research Institute","correspondingAuthor":false,"prefix":"","firstName":"Wei","middleName":"","lastName":"Xue","suffix":""},{"id":474028405,"identity":"1771629d-fde5-4a94-9fb3-8eb5f2f5c8e7","order_by":10,"name":"Haiqi Lu","email":"","orcid":"","institution":"Sir Run Run Shaw Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Haiqi","middleName":"","lastName":"Lu","suffix":""},{"id":474028406,"identity":"89691519-54b1-45c7-a5f6-18d6d01b14e6","order_by":11,"name":"Jun Zhou","email":"","orcid":"","institution":"Women's Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Jun","middleName":"","lastName":"Zhou","suffix":""},{"id":474028407,"identity":"6e4f219f-9d4c-4e95-840f-e30e3437d4c2","order_by":12,"name":"Jinhua Ding","email":"","orcid":"","institution":"Lihuili Hospital, Ningbo, China","correspondingAuthor":false,"prefix":"","firstName":"Jinhua","middleName":"","lastName":"Ding","suffix":""},{"id":474028408,"identity":"a5fe971b-b1ce-4a8b-874c-46c77670d435","order_by":13,"name":"Haiming Deng","email":"","orcid":"","institution":"Xiangfu Health Center, Hangzhou, China","correspondingAuthor":false,"prefix":"","firstName":"Haiming","middleName":"","lastName":"Deng","suffix":""},{"id":474028409,"identity":"dcf330ef-bd06-43da-b21f-59cf016c8051","order_by":14,"name":"Jiaying Chen","email":"","orcid":"","institution":"The First Affiliated Hospital of Zhejiang Chinese Medical University","correspondingAuthor":false,"prefix":"","firstName":"Jiaying","middleName":"","lastName":"Chen","suffix":""},{"id":474028410,"identity":"d79f86b4-b6a4-4b0e-abe5-7096b290e4fe","order_by":15,"name":"Zhuohang Yu","email":"","orcid":"","institution":"Second Affiliated Hospital,Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Zhuohang","middleName":"","lastName":"Yu","suffix":""},{"id":474028411,"identity":"5d3e77b3-5e48-4acf-a424-d6b8d187b259","order_by":16,"name":"Yao Yao","email":"","orcid":"","institution":"Second Affiliated Hospital,Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Yao","middleName":"","lastName":"Yao","suffix":""},{"id":474028412,"identity":"c4b38b5c-e815-4f7d-a98d-bc89d5352c18","order_by":17,"name":"Wenjie Xia","email":"","orcid":"","institution":"Zhejiang Provincial People's Hospital","correspondingAuthor":false,"prefix":"","firstName":"Wenjie","middleName":"","lastName":"Xia","suffix":""},{"id":474028413,"identity":"5d3190be-c0eb-4b7b-8704-3ac623d221f8","order_by":18,"name":"Wuzhen Chen","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Wuzhen","middleName":"","lastName":"Chen","suffix":""},{"id":474028414,"identity":"8af6c574-6240-49d9-a797-2029ba7086e0","order_by":19,"name":"Shanshan Sun","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Shanshan","middleName":"","lastName":"Sun","suffix":""},{"id":474028415,"identity":"7e661ce2-e9b6-4fd2-9c77-673c61fc0a36","order_by":20,"name":"Zhen Wang","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Zhen","middleName":"","lastName":"Wang","suffix":""},{"id":474028416,"identity":"ee27e3b2-3a0a-432f-86ed-e86c9ef9e8bb","order_by":21,"name":"Tianyi Qian","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Tianyi","middleName":"","lastName":"Qian","suffix":""},{"id":474028417,"identity":"b3bd44c3-26ec-4dc2-9006-586b0237361e","order_by":22,"name":"Xiuyan Yu","email":"","orcid":"","institution":"Second Affiliated Hospital, Zhejiang University School of Medicine","correspondingAuthor":false,"prefix":"","firstName":"Xiuyan","middleName":"","lastName":"Yu","suffix":""},{"id":474028418,"identity":"3252ef26-43ba-4def-9795-461415ce611b","order_by":23,"name":"Jian Liu","email":"","orcid":"","institution":"Affiliated Hangzhou First People's Hospital","correspondingAuthor":false,"prefix":"","firstName":"Jian","middleName":"","lastName":"Liu","suffix":""},{"id":474028419,"identity":"04d4b90e-f386-4f2d-aac9-e25066b896c4","order_by":24,"name":"Yi-Ding Chen","email":"","orcid":"https://orcid.org/0000-0002-2263-6275","institution":"Zhejiang University","correspondingAuthor":false,"prefix":"","firstName":"Yi-Ding","middleName":"","lastName":"Chen","suffix":""},{"id":474028420,"identity":"8483fb78-114f-48b3-8879-79057420f71e","order_by":25,"name":"Jian Huang","email":"","orcid":"","institution":"","correspondingAuthor":false,"prefix":"","firstName":"Jian","middleName":"","lastName":"Huang","suffix":""},{"id":474028421,"identity":"08a465c8-3cb7-4b06-8ba2-23f8878ef115","order_by":26,"name":"Ziao Lin","email":"","orcid":"https://orcid.org/0009-0003-7436-1415","institution":"OmixScience Co., Ltd.,","correspondingAuthor":false,"prefix":"","firstName":"Ziao","middleName":"","lastName":"Lin","suffix":""}],"badges":[],"createdAt":"2025-06-11 01:30:11","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6866836/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6866836/v1","draftVersion":[],"editorialEvents":[{"content":"https://doi.org/10.1038/s41467-026-70204-w","type":"published","date":"2026-03-06T05:00:00+00:00"}],"editorialNote":"","failedWorkflow":false,"files":[{"id":104408497,"identity":"4cee6113-e644-48ad-a4b7-1a6ae874da54","added_by":"auto","created_at":"2026-03-11 12:42:42","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":2094800,"visible":true,"origin":"","legend":"","description":"","filename":"NCcfDNA.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6866836/v1_covered_f098279e-04f9-4673-925c-98c61bbdd18a.pdf"},{"id":87068557,"identity":"b531a1a1-7219-48d6-9b4c-5cd2ed573de7","added_by":"auto","created_at":"2025-07-18 19:20:32","extension":"xlsx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":11911,"visible":true,"origin":"","legend":"Supplementary Table 1","description":"","filename":"SupplementaryTable1.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6866836/v1/61855c576ed9891ba94d5f93.xlsx"},{"id":87068558,"identity":"4707f519-daac-45d2-a156-67eeff9879c1","added_by":"auto","created_at":"2025-07-18 19:20:32","extension":"xlsx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":11049,"visible":true,"origin":"","legend":"Supplementary Table 2","description":"","filename":"SupplementaryTable2.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-6866836/v1/e01cdb1dca59d36ac1336bf5.xlsx"},{"id":87068559,"identity":"4c84c22a-47e1-4cc4-ae46-fc3d262baaf9","added_by":"auto","created_at":"2025-07-18 19:20:32","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":15727,"visible":true,"origin":"","legend":"Supplementary Table 3","description":"","filename":"SupplementaryTable3.docx","url":"https://assets-eu.researchsquare.com/files/rs-6866836/v1/96bca4afd573b5313d1c284e.docx"},{"id":87068997,"identity":"cd8f8680-65e9-45f8-9588-04bf8fed0b1a","added_by":"auto","created_at":"2025-07-18 19:28:32","extension":"docx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":14905,"visible":true,"origin":"","legend":"Supplementary Table 4","description":"","filename":"Supplementarytable4.docx","url":"https://assets-eu.researchsquare.com/files/rs-6866836/v1/290576f95adb6d5854c2c5de.docx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Fragmentomic Liquid Biopsy Enables Non-invasive Detection, Molecular Subtyping and Lymph Node Assessment in Early Breast Cancer","fulltext":[],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":false,"highlight":"","institution":"","isAcceptedByJournal":true,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":true,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"nature-portfolio","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"","title":"Nature Portfolio","twitterHandle":"","acdcEnabled":false,"dfaEnabled":false,"editorialSystem":"ejp","reportingPortfolio":"","inReviewEnabled":true,"inReviewRevisionsEnabled":false},"keywords":"Breast cancer, early detection, cell-free DNA, whole-genome sequencing, machine learning","lastPublishedDoi":"10.21203/rs.3.rs-6866836/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6866836/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003eBreast cancer (BC) remains a leading global health concern in women. While mammography is the standard screening tool, its efficacy is limited by the high breast density and accessibility challenges in China. Here, we conducted a multicenter case-control study (NCT06016790) involving 503 patients with malignant BC and 289 benign controls across seven hospitals to develop TuFEst, a machine learning model utilizing multi-feature cell-free DNA (cfDNA) fragmentomics. TuFEst showed excellent early detection performance (95.0% sensitivity and 78.3% specificity), maintaining 96.2% accuracy in an imaging-pathological inconsistency cohort (n=26). To broaden its clinical application, we extended TuFEst to molecular subtyping (TuFEst-MS) and lymph node metastasis prediction (TuFEst-LN). TuFEst-MS yielded AUCs of 0.906 (ER\u003csup\u003e+\u003c/sup\u003e/PR\u003csup\u003e+\u003c/sup\u003eHER2\u003csup\u003e−\u003c/sup\u003e), 0.925 (HER2\u003csup\u003e+\u003c/sup\u003e), and 0.891 (triple-negative) with 85.7% accuracy in the oligometastatic validation cohort (n=21). TuFEst-LN achieved a negative predictive value (NPV) of 95.2%, which improved to 97.6% in an independent cohort (n=124) with discordant axillary imaging pathology. RNA-seq of paired bulk tumor samples (n=79) demonstrated that elevated TuFEst-derived cancer scores were associated with aggressive tumor characteristics, particularly enriched immune responses and epithelial-mesenchymal transition (EMT) signatures, emphasizing the clinical importance of early detection. Our study established cfDNA fragmentomics as an integrated liquid biopsy solution for BC management, enabling concurrent detection, molecular subtyping, and lymph node evaluation with transformative clinical potential.\u003c/p\u003e","manuscriptTitle":"Fragmentomic Liquid Biopsy Enables Non-invasive Detection, Molecular Subtyping and Lymph Node Assessment in Early Breast Cancer","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-07-18 19:20:27","doi":"10.21203/rs.3.rs-6866836/v1","editorialEvents":[],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"nature-communications","isNatureJournal":true,"hasQc":false,"allowDirectSubmit":false,"externalIdentity":"NCOMMS","sideBox":"Learn more about [Nature Communications](http://www.nature.com/ncomms/)","snPcode":"","submissionUrl":"https://mts-ncomms.nature.com/","title":"Nature Communications","twitterHandle":"","acdcEnabled":true,"dfaEnabled":true,"editorialSystem":"ejp","reportingPortfolio":"Nature Communications","inReviewEnabled":true,"inReviewRevisionsEnabled":false}}],"origin":"","ownerIdentity":"f727711b-2723-4ee7-984c-f3b12e5dc0da","owner":[],"postedDate":"July 18th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"published-in-journal","subjectAreas":[{"id":50342362,"name":"Biological sciences/Cancer/Gynaecological cancer"},{"id":50342363,"name":"Biological sciences/Computational biology and bioinformatics/Genome informatics"},{"id":50342364,"name":"Biological sciences/Biotechnology/Sequencing"}],"tags":[],"updatedAt":"2026-03-11T12:18:58+00:00","versionOfRecord":{"articleIdentity":"rs-6866836","link":"https://doi.org/10.1038/s41467-026-70204-w","journal":{"identity":"nature-communications","isVorOnly":false,"title":"Nature Communications"},"publishedOn":"2026-03-06 05:00:00","publishedOnDateReadable":"March 6th, 2026"},"versionCreatedAt":"2025-07-18 19:20:27","video":"","vorDoi":"10.1038/s41467-026-70204-w","vorDoiUrl":"https://doi.org/10.1038/s41467-026-70204-w","workflowStages":[]},"version":"v1","identity":"rs-6866836","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6866836","identity":"rs-6866836","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-05-20T01:45:00.602351+00:00